rs111033283
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PP3_StrongPP5_Very_Strong
The NM_000260.4(MYO7A):c.640G>A(p.Gly214Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Publications
- nonsyndromic genetic hearing lossInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive nonsyndromic hearing loss 2Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, G2P
- Usher syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, PanelApp Australia
- Usher syndrome type 1BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal dominant nonsyndromic hearing loss 11Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Usher syndrome type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYO7A | NM_000260.4 | c.640G>A | p.Gly214Arg | missense_variant | Exon 7 of 49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYO7A | ENST00000409709.9 | c.640G>A | p.Gly214Arg | missense_variant | Exon 7 of 49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
| MYO7A | ENST00000458637.6 | c.640G>A | p.Gly214Arg | missense_variant | Exon 7 of 49 | 1 | ENSP00000392185.2 | |||
| MYO7A | ENST00000409619.6 | c.607G>A | p.Gly203Arg | missense_variant | Exon 8 of 50 | 1 | ENSP00000386635.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152218Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000803 AC: 2AN: 249172 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461682Hom.: 0 Cov.: 32 AF XY: 0.0000193 AC XY: 14AN XY: 727124 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152218Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74362 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:3
- -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 9382091, 29490346, 31456290, 31589614, 34948090, 23451239, 31479088, 24199935, 31964843, 26969326, 16470552, 22135276, 21436283, 25468891, 20497194, 33671976, 28944237, 18181211, 26186295, 10930322, 10704189, 33576163, 37811145, 19683999) -
This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 214 of the MYO7A protein (p.Gly214Arg). This variant is present in population databases (rs111033283, gnomAD 0.006%). This missense change has been observed in individual(s) with Usher syndrome (PMID: 9382091, 16470552, 20497194, 24199935, 26969326). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 43327). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYO7A protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Usher syndrome Pathogenic:1
- -
Usher syndrome type 1B Pathogenic:1
- -
Usher syndrome type 1 Pathogenic:1
- -
Usher syndrome type 1;C1832475:Autosomal dominant nonsyndromic hearing loss 11;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
- -
Rare genetic deafness Pathogenic:1
The p.Gly214Arg variant in MYO7A has been reported in over 10 probands with Ushe r syndrome who were either homozygous for the variant or compound heterozygous w ith a second pathogenic or likely pathogenic variant in MYO7A (Adato 1997, Apari si 2013, Bujakowska 2014, Jaijo 2011, Jaijo 2009, Jaijo 2006, Le Quesne Stabej 2 012, Riazuddin 2008, Roux 2011, LMM data). It has not been identified in large p opulation studies. Computational prediction tools and conservation analyses sugg est that this variant may impact the protein. In summary, this variant meets our criteria to be classified as pathogenic for Usher syndrome in an autosomal rece ssive manner based on its presence in homozygosity or compound heterozygosity wi th a second pathogenic allele in many individuals with Usher syndrome, and low f requency in the general population. -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at